Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Analysis of blood component transfusion and some adverse reactions in myelodysplastic syndroms patients

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Publication Information:
      Institute of Blood Transfusion of Chinese Academy of Medical Sciences, 2023.
    • Publication Date:
      2023
    • Collection:
      LCC:Diseases of the blood and blood-forming organs
      LCC:Medicine
    • Abstract:
      Objective To analyze the blood transfusion and adverse reactions in myelodysplastic syndroms (MDS) patients, so as to improve transfusion management in MDS patients. Methods The diagnosis and treatment information of MDS patients with blood transfusion in our hospital from January 2003 to December 2022 were collected, and the component transfusion and adverse reactions were investigated. Results The average infusion volume of red blood cells(RBCs) and platelets were respectively (27.46±43.11 ) and (16.41±24.81 ) in 799 MDS patients, which had no correlation with gender and blood type. The incidence of adverse reactions was 18.27% (146/799), with the most common adverse reactions as delayed serologic transfusion reaction (DSTR) (9.01%, 72/799), followed by non hemolytic fever reaction (4.76%, 38/799) and allergic reaction (4.38%, 35/799). Compared with all patients with transfusion, DSTR was more common in females (P
    • File Description:
      electronic resource
    • ISSN:
      1004-549X
      1004-549x
    • Relation:
      https://www.cjbt.cn/thesisDetails#10.13303/j.cjbt.issn.1004-549x.2023.08.008&lang=en; https://doaj.org/toc/1004-549X
    • Accession Number:
      10.13303/j.cjbt.issn.1004-549x.2023.08.008&lang=en
    • Accession Number:
      10.13303/j.cjbt.issn.1004-549x.2023.08.008
    • Accession Number:
      edsdoj.0bee6e15754648bab67976080c634555